{
  "trial_id": "NCT04460326",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, BMI, duration of type 2 diabetes, baseline hemoglobin A1c, baseline blood glucose levels, prior diabetes management regimen, serum creatinine levels, history of gastroparesis or cirrhosis, presence of hyperglycemia during admission, expected duration of hospitalization, insulin glargine dosing schedule.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Diabetes treatment prior to admission",
          "prior diabetes management regimen"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "BMI",
        "duration of type 2 diabetes",
        "baseline hemoglobin A1c",
        "baseline blood glucose levels",
        "serum creatinine levels",
        "history of gastroparesis or cirrhosis",
        "presence of hyperglycemia during admission",
        "expected duration of hospitalization",
        "insulin glargine dosing schedule."
      ]
    },
    "processed-gen-response": "Age, sex, BMI, duration of type 2 diabetes, baseline hemoglobin A1c, baseline blood glucose levels, prior diabetes management regimen, serum creatinine levels, history of gastroparesis or cirrhosis, presence of hyperglycemia during admission, expected duration of hospitalization, insulin glargine dosing schedule."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Baseline Blood Glucose, Insulin Dose, Use of Oral/Injectable Agents, Serum Creatinine,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Diabetes treatment prior to admission",
          "Use of Oral/Injectable Agents"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Duration of Diabetes",
        "Baseline HbA1c",
        "Body Mass Index",
        "Baseline Blood Glucose",
        "Insulin Dose",
        "Serum Creatinine"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Baseline Blood Glucose, Insulin Dose, Use of Oral/Injectable Agents, Serum Creatinine"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Hemoglobin A1c, Diabetes Duration, Insulin Dose, History of Hypertension, History of Cardiovascular Disease,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Diabetes treatment prior to admission",
          "Insulin Dose"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Hemoglobin A1c",
        "Diabetes Duration",
        "History of Hypertension",
        "History of Cardiovascular Disease"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Hemoglobin A1c, Diabetes Duration, Insulin Dose, History of Hypertension, History of Cardiovascular Disease"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, BMI, type 2 diabetes duration, hemoglobin A1c, prior diabetes treatment, insulin dose, comorbidities, hospitalization duration, serum creatinine, point of care and/or venous blood glucose, English proficiency.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Diabetes treatment prior to admission",
          "prior diabetes treatment"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "BMI",
        "type 2 diabetes duration",
        "hemoglobin A1c",
        "insulin dose",
        "comorbidities",
        "hospitalization duration",
        "serum creatinine",
        "point of care and/or venous blood glucose",
        "English proficiency."
      ]
    },
    "processed-gen-response": "Age, sex, BMI, type 2 diabetes duration, hemoglobin A1c, prior diabetes treatment, insulin dose, comorbidities, hospitalization duration, serum creatinine, point of care and/or venous blood glucose, English proficiency."
  }
}